Express Scripts 2017 Public Policy Analysis

We believe prescription drug affordability for all is an issue ripe for bipartisanship in 2018.

2017 Public Policy

The national debate on prescription drug prices continued throughout 2017. Headlines regularly emerged about six-figure drug launch prices, drug makers using creative methods to avoid competition, and varied appeals for lawmakers to do something about the problem. In the presence of bipartisan outrage, bipartisan policy ideas seemed elusive, despite more than 140 bills filed this Congress that addressed prescription drug pricing.

Even with high drug prices in the public eye, lawmakers have yet to coalesce around legislation to address the issue. Express Scripts has outlined viable, cost-saving policy ideas for public and private payers.

Read about three areas of policy focus that are ripe for legislative and/or regulatory attention.

Download Express Scripts Public Policy Analysis.


Click to return to the Drug Trend Report landing page.